S&P 500   4,556.19 (-0.46%)
DOW   34,594.61 (-0.13%)
QQQ   385.40 (-1.16%)
AAPL   162.62 (-0.70%)
MSFT   325.14 (-1.32%)
FB   306.07 (-1.39%)
GOOGL   2,860.83 (+0.05%)
AMZN   3,407.60 (-0.87%)
TSLA   1,050.33 (-3.16%)
NVDA   309.49 (-3.66%)
BABA   110.66 (-9.30%)
NIO   33.41 (-7.71%)
CGC   9.90 (-4.44%)
AMD   145.46 (-3.46%)
GE   93.32 (-2.01%)
MU   82.37 (-0.62%)
T   23.13 (+0.35%)
F   19.62 (-1.26%)
DIS   145.49 (-1.16%)
PFE   53.33 (+0.55%)
AMC   28.58 (-5.61%)
ACB   5.94 (-3.26%)
BA   198.25 (-2.04%)
S&P 500   4,556.19 (-0.46%)
DOW   34,594.61 (-0.13%)
QQQ   385.40 (-1.16%)
AAPL   162.62 (-0.70%)
MSFT   325.14 (-1.32%)
FB   306.07 (-1.39%)
GOOGL   2,860.83 (+0.05%)
AMZN   3,407.60 (-0.87%)
TSLA   1,050.33 (-3.16%)
NVDA   309.49 (-3.66%)
BABA   110.66 (-9.30%)
NIO   33.41 (-7.71%)
CGC   9.90 (-4.44%)
AMD   145.46 (-3.46%)
GE   93.32 (-2.01%)
MU   82.37 (-0.62%)
T   23.13 (+0.35%)
F   19.62 (-1.26%)
DIS   145.49 (-1.16%)
PFE   53.33 (+0.55%)
AMC   28.58 (-5.61%)
ACB   5.94 (-3.26%)
BA   198.25 (-2.04%)
S&P 500   4,556.19 (-0.46%)
DOW   34,594.61 (-0.13%)
QQQ   385.40 (-1.16%)
AAPL   162.62 (-0.70%)
MSFT   325.14 (-1.32%)
FB   306.07 (-1.39%)
GOOGL   2,860.83 (+0.05%)
AMZN   3,407.60 (-0.87%)
TSLA   1,050.33 (-3.16%)
NVDA   309.49 (-3.66%)
BABA   110.66 (-9.30%)
NIO   33.41 (-7.71%)
CGC   9.90 (-4.44%)
AMD   145.46 (-3.46%)
GE   93.32 (-2.01%)
MU   82.37 (-0.62%)
T   23.13 (+0.35%)
F   19.62 (-1.26%)
DIS   145.49 (-1.16%)
PFE   53.33 (+0.55%)
AMC   28.58 (-5.61%)
ACB   5.94 (-3.26%)
BA   198.25 (-2.04%)
S&P 500   4,556.19 (-0.46%)
DOW   34,594.61 (-0.13%)
QQQ   385.40 (-1.16%)
AAPL   162.62 (-0.70%)
MSFT   325.14 (-1.32%)
FB   306.07 (-1.39%)
GOOGL   2,860.83 (+0.05%)
AMZN   3,407.60 (-0.87%)
TSLA   1,050.33 (-3.16%)
NVDA   309.49 (-3.66%)
BABA   110.66 (-9.30%)
NIO   33.41 (-7.71%)
CGC   9.90 (-4.44%)
AMD   145.46 (-3.46%)
GE   93.32 (-2.01%)
MU   82.37 (-0.62%)
T   23.13 (+0.35%)
F   19.62 (-1.26%)
DIS   145.49 (-1.16%)
PFE   53.33 (+0.55%)
AMC   28.58 (-5.61%)
ACB   5.94 (-3.26%)
BA   198.25 (-2.04%)
NYSE:BAX

Baxter International Stock Forecast, Price & News

$76.94
+0.71 (+0.93%)
(As of 12/3/2021 10:21 AM ET)
Add
Compare
Today's Range
$76.52
$77.01
50-Day Range
$74.57
$82.19
52-Week Range
$73.12
$88.32
Volume
13,432 shs
Average Volume
2.81 million shs
Market Capitalization
$38.52 billion
P/E Ratio
32.19
Dividend Yield
1.49%
Beta
0.59
30 days | 90 days | 365 days | Advanced Chart
Receive BAX News and Ratings via Email

Sign-up to receive the latest news and ratings for Baxter International and its competitors with MarketBeat's FREE daily newsletter.


Baxter International logo

About Baxter International

Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.

Headlines

Hillrom Shareholders Approve Acquisition By Baxter
December 2, 2021 |  markets.businessinsider.com
Baxter International Has Stamina against COVID-19
November 11, 2021 |  nasdaq.com
See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
07181310
Employees
2,020
Year Founded
1931

Sales & Book Value

Annual Sales
$11.67 billion
Cash Flow
$4.87 per share
Book Value
$17.28 per share

Profitability

Net Income
$1.10 billion
Pretax Margin
11.28%

Debt

Price-To-Earnings

Miscellaneous

Free Float
499,742,000
Market Cap
$38.52 billion
Optionable
Optionable

Company Calendar

Last Earnings
10/27/2021
Ex-Dividend
12/02/2021
Today
12/03/2021
Fiscal Year End
12/31/2021
Dividend Payable
1/03/2022
Next Earnings (Estimated)
2/03/2022

Social Links


MarketRank

Overall MarketRank

2.65 out of 5 stars

Medical Sector

31st out of 1,391 stocks

Surgical & Medical Instruments Industry

6th out of 126 stocks

Analyst Opinion: 2.3Community Rank: 4.7Dividend Strength: 3.3Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -












Baxter International (NYSE:BAX) Frequently Asked Questions

Is Baxter International a buy right now?

12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last twelve months. There are currently 4 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Baxter International stock.
View analyst ratings for Baxter International
or view top-rated stocks.

How has Baxter International's stock price been impacted by COVID-19?

Baxter International's stock was trading at $77.97 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, BAX shares have decreased by 1.5% and is now trading at $76.80.
View which stocks have been most impacted by COVID-19
.

Are investors shorting Baxter International?

Baxter International saw a decrease in short interest during the month of November. As of November 15th, there was short interest totaling 6,040,000 shares, a decrease of 21.5% from the October 31st total of 7,690,000 shares. Based on an average daily trading volume, of 2,960,000 shares, the short-interest ratio is presently 2.0 days. Approximately 1.2% of the shares of the company are sold short.
View Baxter International's Short Interest
.

When is Baxter International's next earnings date?

Baxter International is scheduled to release its next quarterly earnings announcement on Thursday, February 3rd 2022.
View our earnings forecast for Baxter International
.

How were Baxter International's earnings last quarter?

Baxter International Inc. (NYSE:BAX) issued its earnings results on Wednesday, October, 27th. The medical instruments supplier reported $1.02 EPS for the quarter, topping analysts' consensus estimates of $0.94 by $0.08. The medical instruments supplier had revenue of $3.23 billion for the quarter, compared to the consensus estimate of $3.23 billion. Baxter International had a net margin of 9.75% and a trailing twelve-month return on equity of 19.94%. Baxter International's revenue was up 8.5% compared to the same quarter last year. During the same period in the prior year, the business earned $0.83 EPS.
View Baxter International's earnings history
.

How often does Baxter International pay dividends? What is the dividend yield for Baxter International?

Baxter International announced a quarterly dividend on Tuesday, November 16th. Investors of record on Friday, December 3rd will be paid a dividend of $0.28 per share on Monday, January 3rd. This represents a $1.12 annualized dividend and a dividend yield of 1.46%. The ex-dividend date is Thursday, December 2nd.
View Baxter International's dividend history
.

Is Baxter International a good dividend stock?

Baxter International pays an annual dividend of $1.12 per share and currently has a dividend yield of 1.49%. Baxter International has been increasing its dividend for 6 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio of Baxter International is 46.86%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Baxter International will have a dividend payout ratio of 28.64% next year. This indicates that Baxter International will be able to sustain or increase its dividend.
View Baxter International's dividend history.

What guidance has Baxter International issued on next quarter's earnings?

Baxter International updated its FY 2021 earnings guidance on Thursday, November, 4th. The company provided earnings per share (EPS) guidance of $3.580-$3.620 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.520. The company issued revenue guidance of $12.49 billion-$12.61 billion, compared to the consensus revenue estimate of $12.61 billion.

What price target have analysts set for BAX?

12 brokers have issued 12-month target prices for Baxter International's stock. Their forecasts range from $80.00 to $100.00. On average, they expect Baxter International's stock price to reach $90.82 in the next year. This suggests a possible upside of 18.3% from the stock's current price.
View analysts' price targets for Baxter International
or view top-rated stocks among Wall Street analysts.

Who are Baxter International's key executives?

Baxter International's management team includes the following people:
  • Joe Almeida, Chairman, President & Chief Executive Officer
  • Giuseppe Accogli, Chief Operating Officer & Executive Vice President
  • James K. Saccaro, Chief Financial Officer & Executive Vice President
  • Paulo Henrique Bolgar, Vice President-Research & Development
  • Robert Felicelli, Head-Global Technical Services

What is José (Joe) Almeida's approval rating as Baxter International's CEO?

506 employees have rated Baxter International CEO José (Joe) Almeida on Glassdoor.com. José (Joe) Almeida has an approval rating of 85% among Baxter International's employees.

What other stocks do shareholders of Baxter International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), Johnson & Johnson (JNJ), Pfizer (PFE), Cisco Systems (CSCO), Honeywell International (HON), Intel (INTC), Abbott Laboratories (ABT), Procter & Gamble (PG), AT&T (T) and Verizon Communications (VZ).

What is Baxter International's stock symbol?

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Who are Baxter International's major shareholders?

Baxter International's stock is owned by many different institutional and retail investors. Top institutional shareholders include Geode Capital Management LLC (1.63%), Caisse DE Depot ET Placement DU Quebec (1.40%), Bank of New York Mellon Corp (0.88%), California Public Employees Retirement System (0.78%), New York State Common Retirement Fund (0.54%) and Sumitomo Mitsui Trust Holdings Inc. (0.35%). Company insiders that own Baxter International stock include Albert P L Stroucken, Andrew Frye, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth and Sean Martin.
View institutional ownership trends for Baxter International
.

Which institutional investors are selling Baxter International stock?

BAX stock was sold by a variety of institutional investors in the last quarter, including Caisse DE Depot ET Placement DU Quebec, Putnam Investments LLC, Handelsbanken Fonder AB, Huntington National Bank, Segall Bryant & Hamill LLC, Goldman Sachs Group Inc., Blackhill Capital Inc., and New York State Common Retirement Fund. Company insiders that have sold Baxter International company stock in the last year include Albert P L Stroucken, and Andrew Frye.
View insider buying and selling activity for Baxter International
or view top insider-selling stocks.

Which institutional investors are buying Baxter International stock?

BAX stock was acquired by a variety of institutional investors in the last quarter, including Eagle Asset Management Inc., Cooke & Bieler LP, Geode Capital Management LLC, AXA S.A., Schroder Investment Management Group, Sit Investment Associates Inc., Capstone Investment Advisors LLC, and Russell Investments Group Ltd..
View insider buying and selling activity for Baxter International
or or view top insider-buying stocks.

How do I buy shares of Baxter International?

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Baxter International's stock price today?

One share of BAX stock can currently be purchased for approximately $76.80.

How much money does Baxter International make?

Baxter International has a market capitalization of $38.45 billion and generates $11.67 billion in revenue each year. The medical instruments supplier earns $1.10 billion in net income (profit) each year or $2.39 on an earnings per share basis.

How many employees does Baxter International have?

Baxter International employs 2,020 workers across the globe.

Does Baxter International have any subsidiaries?

The following companies are subsidiares of Baxter International: ApaTech Limited, Baxter (China) Investment Co. Ltd, Baxter (Hellas) EPE, Baxter (India) Private Limited, Baxter AO, Baxter Belgium SPRL, Baxter Company Ltd, Baxter Corporation (Canada), Baxter Corporation Englewood, Baxter Deutschland GmbH, Baxter Distribution Center Europe SA, Baxter Healthcare (Guangzhou) Company Ltd, Baxter Healthcare (Shanghai) Company Ltd., Baxter Healthcare (Suzhou) Company Ltd, Baxter Healthcare (Thailand) Company Limited, Baxter Healthcare (Tianjin) Co. Ltd., Baxter Healthcare Corporation, Baxter Healthcare Limited, Baxter Healthcare Limited (Hong Kong China), Baxter Healthcare Limited (Taiwan), Baxter Healthcare Pty Ltd, Baxter Healthcare SA, Baxter Healthcare SA (Singapore Woodlands Branch), Baxter Healthcare Trading (Shanghai) Co. Ltd., Baxter Holding B.V., Baxter Hospitalar Ltda., Baxter Incorporated, Baxter Innovations & Business Solutions Private Limited (India), Baxter Limited, Baxter Manufacturing (Thailand) Co. Ltd., Baxter Medical AB, Baxter Oncology GmbH, Baxter Pharmaceutical Solutions LLC, Baxter Pharmaceuticals (Asia) Pte Ltd., Baxter Pharmaceuticals India Pvt Ltd., Baxter Polska Sp. z o.o., Baxter Productos Medicos Ltda., Baxter R and D Europe SPRL, Baxter S.A. de C.V., Baxter S.A.S., Baxter S.L., Baxter S.p.A., Baxter SA, Baxter Sales and Distribution LLC, Baxter Services Europe SA, Baxter Shared Services & Competencies Limited, Baxter de Guatemala Sociedad Anonima, Bieffe Medital S.p.A., Cheetah Medical, Cheetah Medical (Israel) Ltd., Cheetah Medical (UK) Limited, Cheetah Medical Inc., Gambro AB, Gambro Dasco S.p.A., Gambro Dialysatoren GmbH, Gambro Industries SAS, Gambro Lundia AB, Gambro Renal Products Inc., Laboratorios Baxter S.A., RTS Colombia SAS, Synovis Life Technologies Inc., and Synovis Micro Companies Alliance Inc..

When was Baxter International founded?

Baxter International was founded in 1931.

What is Baxter International's official website?

The official website for Baxter International is www.baxter.com.

Where are Baxter International's headquarters?

Baxter International is headquartered at One Baxter Parkway DF2-1W, Deerfield IL, 60015.

How can I contact Baxter International?

Baxter International's mailing address is One Baxter Parkway DF2-1W, Deerfield IL, 60015. The medical instruments supplier can be reached via phone at (224) 948-2000, via email at [email protected], or via fax at 224-948-1813.


This page was last updated on 12/3/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.